前哨淋巴结活检在口腔鳞状细胞癌中的作用:当前证据与未来挑战
本文综述前哨淋巴结活检(SLNB)在口腔鳞状细胞癌(OCSCC)中的应用证据。选择性颈淋巴清扫是浸润深度大于2-4 mm的早期OCSCC当前标准治疗,但多数患者最终病理无淋巴结病变。SLNB为替代方法,浸润深度、淋巴结定位、组织病理学方法、操作者差异、术后并发症及影像技术进展可指导其合理应用。
要点
- 选择性颈淋巴清扫是浸润深度大于2-4 mm的早期OCSCC当前标准治疗,但多数患者最终病理无淋巴结病变。
- SLNB已在多个肿瘤专科用于预后判断、分期和识别隐匿性淋巴结转移。
- 浸润深度、淋巴结定位、组织病理学方法、操作者差异、术后并发症及影像技术进展可指导SLNB在OCSCC中的合理应用。
核心结论
- 本综述旨在讨论SLNB治疗早期OCSCC的当前证据、支持SLNB操作的影像技术以及正在进行的研究。
研究设计与样本
- 本文为综述,讨论SLNB在早期OCSCC治疗中的当前证据、支持SLNB的影像技术及正在进行的研究。
主要发现
- 选择性颈淋巴清扫是浸润深度大于2-4 mm的早期OCSCC当前标准治疗,但多数患者最终病理无淋巴结病变。
- 近期研究显示SLNB在OCSCC中具有潜在临床效用。
- SLNB是许多肿瘤亚专科早期癌症管理中广泛采用的替代方法。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sentinel lymph node biopsy (SLNB) has been used across oncological specialties for prognostication, staging, and identification of occult nodal metastasis. Recent studies demonstrated the potential clinical utility of SLNB in oral cavity squamous cell carcinoma (OCSCC). Elective neck dissection is the current standard of care in early management of OCSCC with depth of invasion greater than 2-4 mm; however, majority of patients ultimately do not have nodal disease on final pathology. SLNB is an alternative procedure widely adopted in early cancer management in many oncological subspecialities. Several considerations such as depth of invasion, nodal mapping, histopathology methods, operator variability, postoperative complications, and advancement in preoperative and intraoperative imaging technology can guide the appropriate application to SLNB in OCSCC. The aim of this review is to discuss the current evidence for SLNB in the treatment of early stage OCSCC, imaging technologies that support SLNB procedures, and studies that are currently underway.
引用
- Jang SS, Davis ME, Vera DR, et al. Role of sentinel lymph node biopsy for oral squamous cell carcinoma: Current evidence and future challenges. Head Neck. 2022. PMID: 36193862. doi:10.1002/hed.27207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。